YBX3 and breast cancer: In bladder cancer (BC), lncRNA BLACAT3 facilitates the nucleocytoplasmic shuttling of YBX3, enhancing its binding to the promoter of the target gene NCF2 and thereby promoting angiogenesis and hematogenous metastasis [44].